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Abstract
Background To describe the real burden of major complications after elective surgery for colon cancer in Norway, and to 
assess which predictors that are significantly associated with the short-term outcome.
Methods An observational, multi-centre analysis of prospectively registered colon resections registered into the Norwegian 
Registry for Gastrointestinal Surgery, NoRGast, between January 2014 and December 2016. A propensity score-adjusted 
subgroup analysis for surgical access groups was attempted, with laparoscopic resections grouped as intention-to-treat.
Results Out of 1812 resections, 14.0% of patients experienced a major complication within 30 days following surgery. The 
over-all reoperation rate was 8.7%, and rate of reoperation for anastomotic leak was 3.8%. Twenty patients (1.1%) died within 
30 days after surgery. Higher age was not a significant predictor of major complications, including 30-day mortality. After 
correction for all co-variables, open access surgery was associated with higher rates of major complications (OR 1.67 (CI 
1.22–2.29), p = 0.002), higher 30-day mortality (OR 4.39 (CI 1.19–16.13) p = 0.026) and longer length-of-stay (HR 0.58 
(CI 0.52–0.65) p < 0.001).
Conclusions Our results indicate a low complication burden and high rate of uneventful patient journeys after elective sur-
gery for colon cancer in Norway. Age was not associated with higher morbidity or mortality rates. Open access surgery was 
associated with an inferior short-term outcome.
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In 2012, Norway reported the world’s 6th highest incidence 
of colorectal cancer [1], and the incidence has for the past 
decades been steadily increasing [2]. The prognosis fol-
lowing surgical treatment is excellent, with a 5-year rela-
tive survival rate of 84% after resection for non-metastatic 
disease [3]. Even the oldest and most frail patients will often 
be offered surgery with curative intent. While the potential 
gain from uneventful surgery is large, the consequences of 
major complications may be devastating with loss of func-
tion and impaired quality of life that are at best temporary. 
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There is also a growing interest for the negative impact from 
non-fatal major surgical complications on long-term cancer 
survival [4–6]. Given its high incidence rate and potentially 
good prognosis, a nationwide high-quality surgical service 
for colon cancer is a vital concern for public health.
While surgery for most other cancer forms (including 
rectal cancer) is centralized, surgery for malignant tumours 
of the colon is still performed in general hospitals in Nor-
way. The Norwegian Colorectal Cancer Registry (NCCR) 
continuously surveys the oncological outcomes on national 
and hospital level, but includes only limited data for major 
complications and risk factors. Randomized controlled tri-
als (RCTs) and selected single-centre series should be com-
plemented by data that illustrate real-life outcomes for all 
patients and all surgeons. The novel Norwegian Registry for 
Gastrointestinal surgery (NoRGast) is a prospective registry 
for colorectal, upper gastrointestinal and hepato-pancreato-
biliary (HPB) surgery that offers readily available outcome 
data for a national cohort and includes core case-mix fac-
tors for risk adjustment [7]. The registry is procedure based, 
and all formal HPB or gastrointestinal resections are eligible 
for inclusion. Data are entered by a health care professional 
through a secured web portal. All Norwegian hospitals, 
ranging from large tertiary colorectal, upper GI or HPB units 
to small general hospitals performing less than 20 colonic 
resections per year are invited to contribute. Contribution 
was initially voluntarily, but as the registry received status 
as a national quality registry in 2016, the registration has 
since been made mandatory.
The aim of this study was to describe the real-life compli-
cation burden after elective resections for colonic cancer in 
Norway, and to assess factors that influence the short-term 
outcome.
Methods
NoRGast started data collection in 2014 and holds by entry 
of 2018 data for over 17,000 resections for both malignant 
and benign disease. The dataset includes patient baseline 
data, procedural characteristics and outcomes prospectively 
registered by the operating unit under index admission and 
at a 30-day follow-up. This is described in more detail else-
where [7]. ERAS has been endorsed by all hospitals follow-
ing a series of national symposia. However, this registry 
does not hold any data that assess the degree of compliance 
to standard protocols.
Data from all colonic resections performed between 
01.01.2014 and 01.12.2016 were retrieved from the NoR-
Gast database. The included resections were grouped 
by NCSP-codes [8] as “ileocecal resections and right 
hemicolectomies” (JFB 20-21-30-31-33-34), “resections 
of the transverse colon and left hemicolectomies” (JFB 
40-41-43-44), “sigmoid resections” (JFB 46-47-53-54-
60-61) and “subtotal, total and other colectomies” (JFB 
50-51-63-64 and JFH 00-01-10-11). Only resections 
performed for confirmed or strongly suspected colonic 
neoplasia were included. These were identified by hav-
ing a corresponding ICD-diagnosis [9] denoting cancer 
or neoplasia (C18.0-9, C19, D01.0-1, D12.0-7, D37.2-4 
or K63.5). Non-scheduled surgery, defined by start of 
anaesthesia between 4 p.m. and 8 a.m. or performed dur-
ing weekends and public holidays, was excluded. Tumour 
stage is not recorded in the registry and was accordingly 
not included in this analysis.
All patients included in NoRGast have given written con-
sent to have their data stored in the registry, and the regis-
ter holds a data storage licence from the Norwegian Data 
Authority. The study was approved by both the Regional 
Ethics Committee and the Data Protection Officer, and per-
formed within the limits and regulations of the written con-
sent already obtained.
Severe pulmonary disease (FEV1 < 50% and or vital 
capacity < 60%) and severe cardiac disease (NYHA class 
3 or 4, or severe arrhythmia requiring mechanical support) 
were defined in concordance with the modified Estimation of 
Physiologic Ability and Surgical Stress (mE-PASS) defini-
tions [10]. Weight loss was defined as weight loss of any size 
calculated from patient-reported weight 6 months prior to 
surgery and scaled weight upon admission. Surgical access 
modality was analysed as intention-to-treat, comparing all 
intended laparoscopic resections (completed or converted to 
open procedure) to primarily open resections. CRP and albu-
min levels used in the modified Glasgow Prognostic Score 
(mGPS) were measured within 3 weeks preoperatively.
The Accordion system for grading postoperative compli-
cations is used in the registry [11]. Briefly, any percutane-
ous, angiographic or endoscopic intervention is classified 
as Accordion grade 3, reoperation with new access to the 
abdomen or single organ failure (SOF) as Accordion grade 
4, reoperation and SOF, or multi-organ failure (MOF) as 
Accordion grade 5, and death as Accordion grade 6 [11]. 
Only the highest graded complication is scored for any given 
patient. The primary outcome was any major complication 
(defined as Accordion grade 3 or higher) occurring within 
30 days after index surgery with separate sub-analyses for 
reoperation, anastomotic leak (AL) and mortality. All major 
complications occurring during transfer- or readmission 
stays within 30 days were also included. AL was defined 
as reoperation with anastomotic dehiscence as the primary 
intraoperative finding. Only resections where a new anasto-
mosis was fashioned were included in analysis of AL rates. 
Deep infection near the anastomosis was classified as AL 
if discovered upon reoperation, but classified as accordion 
grade 3 (and omitted from AL definition) if solely percutane-
ous drainage was performed.
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For univariable analyses, Pearson Chi square or Fischer 
exact test (as fit) was used for categorical data, and two-
sided t-test was used for continuous variables. Unadjusted 
odds ratios (OR) were computed for crude effect measure. 
A backward, step-wise method for binary logistic regres-
sion was used to further explore associations between pre-
dictors and outcomes, with adjusted OR (aOR) estimated 
for effect size. Only predictors with a p-value < 0.05 in 
univariable analysis for each outcome were included. To 
assess the regression model for possible multicollinearity, 
the variance inflation factor was computed. For subgroup 
analyses, comparing outcomes for access modality, a pro-
pensity score correcting for skewness in baseline charac-
teristics was calculated [12]. The propensity score was then 
included in a second binary logistic regression together with 
access modality, age and gender. Correction with propen-
sity score in logistic regression was chosen over propensity 
score matching due to minor baseline differences in the two 
access groups. Patients with missing values were selectively 
excluded from the univariate analyses, and for regression 
analyses, patients with any missing value were excluded. 
Predictors with a level of missing values above 20% were 
excluded from analyses. Age was grouped for univariable 
analyses, but analysed as a continuous variable in regres-
sion analyses. Significance level was set to p < 0.05, and all 
confidence intervals were 95%. SPSS 24 software (IBM) was 
used for all analyses.
The manuscript was drafted in accordance with the 
STROBE guidelines for observational studies [13].
Results
Data from 2778 colon resections performed between 1 Janu-
ary 2014 and 15 December 2016 were retrieved from the 
NoRGast database. Of these, 966 patients were excluded 
for either having a main diagnosis of non-neoplastic dis-
ease (n = 711), start of anaesthesia between 4 p.m. and 
8 a.m. indicating non-scheduled surgery (n = 108) or both 
(n = 147), leaving 1812 eligible patients for further analysis. 
See flowchart (Fig. 1). A total of 960 resections (53.0%) 
were completed by laparoscopic technique, 109 resections 
(10.2% of all commenced as laparoscopy) were converted to 
open technique, and 743 (41.0%) were primarily open proce-
dures. Sixteen surgical units contributed data, of which five 
were large academic hospitals and the remaining units were 
general hospitals with a varying annual number of colonic 
resections. The distribution in use of laparoscopy is grouped 
by annual hospital volume and shown in Table 1. The con-
tributing hospitals perform approximately 60% of the annual 
number of colonic resections in Norway. The median num-
ber of included resections from each unit was 138 (range 
24–365) and the median frequency of laparoscopic access 
69.0% (range 28–100). Preoperative weight loss suffered 
from a high number of missing values (47%) due to lack-
ing registration of patient-reported weight 6 months prior to 
surgery, and was excluded from further analysis. The rate of 
missing values was 16.9% for the modified Glasgow Prog-
nostic Score (mGPS), 7.0% for BMI and all other variables 
had a missing value rate of less than 2%.
Of the 1812 resected patients, 249 (14.0%) experienced a 
major complication (Table 2; Fig. 2). Of these 249 patients, 
20 (1.1%) died (i.e. Accordion grade 6). Another 17 patients 
(0.9%) had a grade 5 complication; 171 patients (9.4%) had 
grade 4, and 46 patients (2.5%) a grade 3 complication. In 
univariable analysis, older age, male gender, higher ECOG-, 
mGPS- or ASA-scores and open surgery were all associ-
ated with a higher complication rate. In a multivariable 
model, the higher complication rates observed with higher 
mGPS (aOR mGPS 0 to 2: 1.82 (CI 1.17–2.82)) and ASA-
scores (aOR ASA 1 to 3: 2.27 (CI 1.06–4.87)) as well as 
open access technique (aOR 1.55 (CI 1.15–2.10)) remained 
statistically significant. The crude incidences of reinterven-
tions and organ failure stratified by access type are shown 
in Fig. 3.
A total of 158 patients (8.7%) had a reoperation within 
30 days (Table 3). Of these, 146 patients had a reoperation 
during the index stay and 26 patients following primary dis-
charge, but within 30 days from index surgery. Main finding 
at reoperation was AL in 62 (39.2%) patients, wound dehis-
cence in 32 (20.3%), intraabdominal bleeding in 11 (7.0%) 
and deep infection not in proximity to the anastomosis in 
9 (5.7%) patients. In 39 patients (24.7%), there were other 
findings, and in five patients (3.2%), there were no specific 
findings upon reoperation. Male gender, open access and 
resection type were significant single predictors for undergo-
ing a reoperation. In multivariable analysis, only male gen-
der (aOR 1.48 (CI 1.06–2.06)) and resection type remained 
statistically significant.
Some 1663 patients (91.8%) had a new anastomosis fash-
ioned at index surgery, of whom 62 (3.7%) had a reoperation 
with AL as primary finding (Table 4). The only significant 
predictor of AL requiring reoperation was resection type 
(aOR for AL with ileocecal and right hemicolectomies as 
reference: transversal and left hemicolectomies 2.46 (CI 
1.23–4.93) and subtotal, total and other colectomies 2.20 
(CI 1.40–8.83)).
Twenty patients died within 30 days, yielding an overall 
30-day mortality rate of 1.1% (Table 5). Older age, higher 
WHO-ECOG-, mGPS- or ASA-score, pulmonary comor-
bidity, cardiac comorbidity and open access were signifi-
cant predictors in univariable analysis. After multivariable 
analysis, only open access (aOR 2.87 (CI 1.08–7.59)), severe 
pulmonary disease (aOR 4.95 (CI 1.83–13.31)) and severe 
cardiac disease (aOR 2.92 (CI 1.09–7.82)) remained statis-
tically significant predictors of death. Fourteen of the 20 
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patients who died did not undergo a reoperation. The mor-
tality rate at 30 days was 1.9% (14 out of 743) after open 
surgery and 0.6% (6 out of 1069) after laparoscopic surgery 
(p = 0.008).
Some 177 patients (9.8%) were readmitted within 30 
days; either to index hospital (n = 160) or another hospi-
tal (n = 17). The readmission rates among patients who had 
anastomosis fashioned during index surgery was 9.6% (160 
out of 1664) compared to 11.5% (17 out of 148) of those 
who did not have new anastomosis. A total of 26 patients 
had a reoperation during the readmission stay, of whom 7 
also had a reoperation during the index stay. The overall 
LoS was mean 7.4 days and median 5 days (IQR 4–8), with 
median LoS for laparoscopic and open resections of 4 days 
(IQR 3–6) and 7 days (IQR 5–11), respectively.
At the time of surgery, 452 patients (25.0%) in the cohort 
were older than 80 years. Of these, 82.5% did not experience 
Fig. 1  Flowchart for inclusion 
and categorization according to 
access modality for sub analyses
Table 1  Distribution of annual resection volume per hospital unit and 
use of laparoscopy
a Annual number of resections for colon cancer (source: Colorectal 
Cancer Registry of Norway, National report 2015, reference [3])
b Number of resections in the current cohort operated upon in a hospi-
tal unit within the corresponding volume group
c Percentage of resections in the current cohort performed with lapa-






Resections (n)b Laparoscopy 
(% (range))c
< 50 5 256 80 (62–100)
50–100 7 772 64 (41–100)
> 100 4 784 47 (28–80)
Total 16 1812 67 (28–100)
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any major complication, and 30-day mortality was 2.2%. 
After covariable adjustment, age was not a statistically sig-
nificant predictor for major complications. A high fraction 
of patients had a new anastomosis fashioned and this did 
not differ between age groups. There was a lower rate of AL 
requiring reoperation (3.1%) observed in the > 80 group, but 
Table 2  Univariable and 
multivariable analyses of 
association between the 
predictors and any major 
complication (Accordion score 
3–6) within 30 days
Bold values indicate statistical significance at p < 0.05
a Values in parenthesis are 95% confidence intervals
b Chi square tests
c Logistic regression analyses
d IC: ileocecal resection, RHC: right hemicolectomy, SR: sigmoid resection, TRR: transversal resection, 
LHC: left hemicolectomy, SC: subtotal colectomy, TC: total colectomy
n Rate (%) Univariable Multivariable
OR  (CIa) pb Adjusted OR  (CIa) pc
All patients 1812 14.0
Age group
 < 65 475 12.6 Ref 0.049 – –
 65–80 885 13.0 1.03 (0.74–1.43)
 > 80 452 17.5 1.46 (1.02–2.11)
Gender
 Female 959 12.3 Ref 0.026 – –
 Male 853 15.9 1.35 (10.4–1.76)
WHO ECOG-score
 0 or 1 1529 14.1 Ref 0.058 – –
 > 1 245 19.6 1.41 (0.99–2.02)
mGPS
 0 1080 13.7 Ref 0.004 Ref 0.022
 1 278 15.7 1.12 (0.77–1.64) 0.97 (0.66–1.42)
 2 146 25.3 2.02 (1.32–3.09) 1.82 (1.17–2.82)
ASA-score
 I 121 6.6 Ref < 0.001 Ref 0.021
 II 994 12.8 1.94 (0.92–4.07) 1.50 (0.70–3.18)
 III 650 19.5 3.17 (1.50–6.66) 2.27 (1.06–4.87)
 IV 46 15.2 2.54 (0.86–7.45) 2.12 (0.68–6.44)
Severe pulmonary disease
 No 1681 13.7 Ref 0.132 – –
 Yes 130 18.5 1.43 (0.90–2.27)
Severe cardiac disease
 No 1611 13.6 Ref 0.134 – –
 Yes 200 17.5 1.35 (0.91–2.00)
Weight class (BMI)
 < 18.5 69 14.5 0.98 (0.48–1.97) 0.744 – –
 18.5–25 683 15.8 Ref
 25–30 650 13.1 0.84 (0.62–1.15)
 > 30 283 15.9 0.98 (0.66–1.45)
Access
 Laparoscopy 1069 10.5 Ref < 0.001 Ref 0.004
 Open 743 19.1 2.02 (1.54–2.64) 1.55 (1.15–2.10)
Resection  typed
 IC and RHC 1032 13.5 Ref 0.003 – –
 SR 476 11.1 0.81 (0.58–1.13)
 TRR and LHC 196 19.9 1.60 (1.08–2.37)
 SC/TC and both 108 21.3 1.74 (1.06–2.85)
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higher age was not associated with lower AL rate (OR 0.98, 
CI (0.96–1.00) p = 0.063).
Open access technique was associated with an inferior 
outcome when compared to laparoscopic access. Sev-
eral baseline characteristics differed between the surgi-
cal access groups, with a trend indicating that patients 
operated upon with open technique were somewhat more 
high-risk than those who underwent a laparoscopic pro-
cedure (Table 6). Therefore, we performed a regression 
analysis of access as a predictor adjusted with a propensity 
score correcting for baseline differences between the two 
surgical access groups (Table 7). A difference in disfavour 
Fig. 2  The distribution in sever-
ity of major postoperative com-
plications presented as cumula-
tive percentages of Accordion 
grade 3–6. In accordance with 
the Accordion system, only 
the highest graded complica-
tion is scored for any given 
patient journey. The cumulative 
percentages of Accordion score 
3–6 are shown in the end of 
each column. Separate columns 
are given for the two access 
groups, and further stratified 
for age group with a cut-off of 
80 years
Fig. 3  Crude incidences of all 
recorded reinterventions and 
organ failures within 30 days 
from index surgery. Notably, in 
contrast to the Accordion scale 
where only the most severe 
complication for each patient 
journey is graded (Fig. 2), all 
events are here counted under 
the respective type of reinter-
vention or organ failure group
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of open technique remained statistically significant for rate 
of any major complication (aOR 1.67 (CI 1.22–2.29)), 
30-day mortality (aOR 4.39 (CI 1.19–16.13)) and LoS 
(aHR 0.58 (0.52–0.65)).
Table 3  Univariable and 
multivariable analyses of 
association between the 
predictors and reoperation of 
any cause within 30 days
Bold values indicate statistical significance at p < 0.05
a Values in parenthesis are 95% confidence intervals
b Chi square tests
c Logistic regression analyses
d IC: ileocecal resection, RHC: right hemicolectomy, SR: sigmoid resection, TRR: transversal resection, 
LHC: left hemicolectomy, SC: subtotal colectomy, TC: total colectomy
Rate (%) Univariable Multivariable
OR  (CIa) pb Adjusted OR  (CIa) pc
All patients 8.7
Age group
 < 65 8.2 Ref 0.724 – –
 65–80 9.3 1.10 (0.77–1.70)
 > 80 8.2 1.00 (0.62–1.59)
Gender
 Female 7.4 Ref 0.024 ref 0.020
 Male 11.0 1.46 (1.05–2.03) 1.48 (1.06–2.06)
WHO ECOG-score
 0 or 1 9.0 Ref 0.602 – –
 > 1 10.0 0.88 (0.53–1.44)
mGPS
 0 9.0 Ref 0.532 – –
 1 6.8 0.77 (0.46–1.29)
 2 10.3 1.11 (0.62–2.01)
ASA-score
 I 2.5 Ref 0.086
 II 8.8 3.77 (1.18–12.18) – –
 III 10.0 4.37 (1.35–14.14)
 IV 6.5 2.74 (0.53–14.12)
Severe pulmonary disease
 No 8.7 Ref 0.830 –
 Yes 9.2 1.07 (0.58–1.98)
Severe cardiac disease
 No 8.6 Ref 0.678 – –
 Yes 10.0 1.11 (0.67–1.84)
Weight class (BMI)
 < 18.5 7.2 0.84 (0.33–2.18) 0.840 – –
 18.5–25 8.9 Ref
 25–30 8.5 0.98 (0.66–1.44)
 > 30 12.0 1.18 (0.74–1.90)
Access
 Laparoscopy 7.6 Ref 0.039 – –
 Open 10.4 1.41 (1.02–1.96)
Resection  typed
 IC and RHC 8.1 Ref 0.003 Ref 0.005
 SR 6.7 0.81 (0.53–1.24) 0.78 (0.51–1.19)
 TRR + LHC 12.2 1.58 (0.97–2.55) 1.55 (0.96–2.51)
 SC/TC and both 16.7 2.26 (1.30–3.92) 2.20 (1.27–3.84)
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Table 4  Univariable and 
multivariable analyses of 
association between the 
predictors and reoperation for 
anastomotic leak (AL) within 
30 days
Bold values indicate statistical significance at p < 0.05
a Rate of patients who had a new anastomosis fashioned
b Values in parenthesis are 95% confidence intervals
c Chi square tests
d Logistic regression analyses
e IC: ileocecal resection, RHC: right hemicolectomy, SR: sigmoid resection, TRR: transversal resection, 




AL rate (%) Univariable Multivariable
OR  (CIb) pc Adjusted OR  (CIb) pd
All patients 91.8 3.8
Age group
 < 65 91.8 4.6 Ref 0.479 – –
 65–80 92.1 3.4 0.74 (0.41–1.33)
 > 80 91.4 3.1 0.68 (0.33–1.38)
Gender
 Female 91.7 3.0 Ref 0.106 – –
 Male 92.0 4.5 1.53 (0.91–2.57)
WHO ECOG-score
 0 or 1 92.3 3.7 Ref 0.999 – –
 > 1 88.6 3.7 1.00 (0.47–2.14)
mGPS
 0 94.3 3.6 Ref 0.940 – –
 1 87.4 3.3 0.80 (0.42–1.97)
 2 87.0 3.1 0.86 (0.30–2.46)
ASA-score
 I 91.7 1.8 Ref
 II 93.6 3.8 2.13 (0.51–8.98)
 III 89.8 4.1 2.34 (0.54–10.03) 0.726 – –
 IV 82.6 0 0
Severe pulmonary disease
 No 91.9 3.7 Ref 0.854 – –
 Yes 91.5 3.4 0.91 (0.32–2.55)
Severe cardiac disease
 No 92.1 3.8 Ref 0.287 – –
 Yes 89.5 2.2 0.57 (0.21–1.60)
Weight class (BMI)
 < 18.5 78.3 1.9 0.64 (0.08–4.91) 0.367 – –
 18.5–25 92.4 2.9 Ref
 25–30 93.4 4.6 1.65 (0.90–3.01)
 > 30 92.6 3.8 1.35 (0.62–2.97)
Access
 Laparoscopy 95.0 3.3 Ref 0.386 – –
 Open 87.2 4.2 1.26 (0.75–2.10)
Resection  typee
 IC and RHC 96.6 2.8 Ref 0.010 Ref 0.010
 SR 88.4 3.6 1.28 (0.68–2.42) 1.28 (0.68–2.42)
 TRR + LHC 92.3 6.6 2.46 (1.23–4.93) 2.46 (1.23–4.93)
 SC/TC and both 60.2 9.2 3.52 (1.40–8.83) 3.52 (1.40–8.83)
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Table 5  Univariable and 
multivariable analyses of 
association between the 
predictors and mortality within 
30 days
Bold values indicate statistical significance at p < 0.05
a Values in parenthesis are 95% confidence intervals
b Chi square tests
c Logistic regression analyses
d IC: ileocecal resection, RHC: right hemicolectomy, SR: sigmoid resection, TRR: transversal resection, 
LHC: left hemicolectomy, SC: subtotal colectomy, TC: total colectomy
Rate (%) Univariable Multivariable
OR  (CIa) pb Adjusted OR  (CIa) pc
All patients 1.1 – – –
Age group
 < 65 0.8 Ref 0.724 – –
 65–80 0.7 0.80 (0.23–2.86)
 > 80 2.2 2.66 (0.83–8.56)
Gender
 Female 1.3 Ref 0.024 – –
 Male 0.9 0.75 (0.30–1.84)
WHO ECOG-score
 0 or 1 0.9 Ref 0.602 – –
 > 1 2.4 2.72 (1.03–7.14)
mGPS
 0 0.7 Ref 0.532 – –
 1 1.4 1.96 (0.59–6.55)
 2 3.4 4.76 (1.54–14.74)
ASA-score
 I 0 0.086 – –
 II 0.3 I + II: ref
 III 2.3 III + IV: 9.28 (2.71–31.79)
 IV 4.3
Severe pulmonary disease
 No 0.8 Ref 0.830 Ref 0.002
 Yes 5.4 7.31 (2.87–18.65) 4.95 (1.83–13.31)
Severe cardiac disease
 No 0.8 Ref 0.678 Ref 0.033
 Yes 3.5 4.46 (1.76–11.32) 2.92 (1.09–7.82)
Weight class (BMI)
 < 18.5 0 0 0.840 – –
 18.5–25 1.5 Ref
 25–30 0.8 0.52 (0.18–1.54)
 > 30 1.1 0.72 (0.20–2.64)
Access
 Laparoscopy 0.6 Ref 0.039 Ref 0.034
 Open 1.9 3.40 (1.30–8.90) 2.87 (1.08–7.59)
Resection  typed
 IC and RHC 1.2 Ref 0.003 – –
 SR 1.1 0.88 (0.20–3.95)
 TRR + LHC 1.0 0.90 (0.32–2.58)




Population-based data for the complication burden and mag-
nitude of impact from risk factors may aid clinicians and 
patients in decision-making and provide essential backdrops 
for interpretation of clinical trials. This multi-centre study 
from both low- and high-volume units throughout Norway 
reveals a low rate of major complications, with low overall 
rates of reoperation, anastomotic leak (AL) requiring reop-
eration and mortality within 30 days.
A high proportion (86.0%) of this unselected cohort did 
not experience any kind of major complication. When com-
pared to other population-based publications, our results are 
in line with reports from the Swedish (8.0% reoperations, 
4.2% AL and 1.4% mortality) [14], and Danish (4.3% AL 
and 1.4% mortality) [15], national colorectal cancer regis-
tries. A recent retrospective single-centre study from Swe-
den reported an AL rate of over 7.0% for colonic resections 
[16]. Notably, AL rates are not directly comparable due to 
diverging definitions, as AL rates in NoRGast do not include 
micro leakages that do not necessitate a reoperation. AL 
requiring only percutaneous drainage would within our reg-
istry be classified as Accordion 3 together with any other 
endoscopic or percutaneous intervention (including drainage 
of pleural effusion). Data from a Dutch national report [17], 
however, corresponds to a rate of reoperations due to AL 
of 6.4% and an overall mortality rate of 3.4% after elective 
colonic surgery, which are both somewhat higher than those 
in the current study.
The overall LoS in our unselected material was short, in 
line with single centre reports from specialized Enhanced 
Recovery After Surgery (ERAS) units and fast-track pro-
grams, and shorter than several population-based studies 
[18–21]. The readmission rate of 9.8% is not exceeding 
readmission rates in reports with longer primary LoS [22, 
23] and hence seems acceptable, reflecting an overall reason-
able discharge policy. The conversion rate of 10.2% of all 
commenced laparoscopy is in line with recent reports from 
other unselected cohorts [24, 25].
Age has both traditionally and in recent publications been 
linked to complicated and prolonged postoperative hospital 
stays [26], but comparable complication rates and survival 
after surgical treatment of octogenarians have also been pub-
lished [27, 28]. This study showed no association between 
higher age and major complications, including mortality. 
The tendency of a low rate of AL requiring reoperation 
among the oldest has been observed in other publications 
[17]. These non-inferior outcomes among the oldest may 
partly be due to younger patients receiving more extensive 
surgery. One may further assume that octo- and nonagenar-
ians undergoing surgery have been carefully selected and 
that the rather crude indicators in the registry have not fully 
captured their low risk profile. Nevertheless, our results indi-
cate that such a selection results in a comparatively good 
outcome in those accepted for surgery.
The non-inferior short-term (non-oncological) outcomes 
after laparoscopic surgery for colon cancer were confirmed 
Table 6  Demographics of analyzed predictors stratified by access 
modality group
Bold values indicate statistical significance at p < 0.05
a Chi square tests
b IC: ileocecal resection, RHC: right hemicolectomy, SR: sigmoid 
resection, TRR: transversal resection, LHC: left hemicolectomy, SC: 
subtotal colectomy, TC: total colectomy
Laparoscopy Open Comparison 
of access 
groups
% of all laparos-
copies




 < 65 29.2 21.9 0.002
 65–80 46.2 52.6
 > 80 24.6 25.4
Gender
 Female 51.6 54.8 0.188
 Male 48.4 45.2
WHO ECOG score
 0 or 1 88.7 82.6 < 0.001
 > 1 11.3 17.4
mGPS









 No 94.4 90.6 0.002
 Yes 5.6 9.4
Severe cardiac disease
 No 90.4 86.9 0.022
 Yes 9.6 13.1
Weight class (BMI)
 < 18.5 3.5 5.0 0.120
 18.5–25 40.9 40.0
 25–30 40.0 36.4
 > 30 15.6 18.5
Resection  typeb
 IC + RHC 56.7 57.3 < 0.001
 SR 30.6 20.1
 TRR + LHC 8.5 14.1
 SC, TC and both 4.2 8.5
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in early RCTs [29, 30]. A recent Japanese RCT reported 
lower morbidity after laparoscopy [31]. While several obser-
vational studies and long-term follow-ups after RCTs indi-
cate a non-inferior long-term survival [32–34], a large pop-
ulation-based European retrospective study even reported 
enhanced survival after laparoscopy [35]. A meta-analysis 
on both short- and long-term outcomes after RCTs suggests 
that laparoscopy may be preferred due to superior short-
term results [36]. A large retrospective report including 
more than 200,000 patients in the US reported, similar to 
our study, diverging results for morbidity, mortality, rate of 
routine discharge and LoS, and concluded with benefits from 
a laparoscopic approach [21]. Although the guidelines from 
the Norwegian Gastrointestinal Cancer Group do not clearly 
recommend either access modality over the other [37], the 
Norwegian Colorectal Cancer Registry (NCCR) measures 
laparoscopy rate as a quality indicator [3, 37]. The rate of 
procedures commenced as laparoscopy in our study (59%) is 
in line with national cohorts from the NCCR for 2014 (52%) 
and 2015 (56%) [3].
The association between surgical access and diverging 
outcomes in our data is strong. The over-all rate of major 
complications was almost twice as high in the open access 
group, and the distribution in severity of complications 
did not differ between the access groups (Fig. 2). Data on 
tumour stage are not included in this registry (NoRGast). 
In a Norwegian national cohort of colon cancer resections 
from 2007 to 2010, 11.7% presented as T4-tumours, of 
which 84.3% were removed by open access [38]. Although 
the limitations of laparoscopic technique have gradually 
reclined, there is a possibility of a higher proportion of large-
sized and T4 tumours in the open access group. Tumour 
size and stage could both affect the choice of access and 
choice of restoration, and contribute to morbidity and hence 
represents a possible confounder. There was a lower rate of 
new anastomosis fashioned in the open surgery group ver-
sus the laparoscopy group (95.0% vs. 87.2%) in the current 
cohort, which may partly be due to inter-access differences 
in resection types performed. There were a larger propor-
tion of sigmoid resections in the laparoscopy group and 
more transverse, left sided and total/subtotal colectomies 
done by open access. As these latter subtypes of colonic 
resections were associated with a higher complication rate, 
resection type was included in the basis of the propensity 
score correction. Its skewing effect on outcomes was hence 
adjusted for but still did not affect the lower complication 
rate following laparoscopic surgery. Furthermore, the lower 
rate of primary reconstruction resulted in a lower proportion 
of patients under risk for AL, and would in theory dimin-
ish the risk of major adverse advents in the open resection 
group. Our results must be interpreted with caution due to 
possible patient selection bias between access modalities 
not revealed by the case-mix factors registered. However, 
the observed large inter-unit variation in use of laparoscopy 
(range 28–100, Table 1) cannot be explained by patient or 
tumour factors alone, and must to some extent be a result of 
diverging attitudes between the units regarding the routine 
use of laparoscopic access .
Some limitations need to be addressed. The included 
resections were registered from 16 separate surgical depart-
ments throughout Norway, and this material does not consti-
tute a complete national cohort. In 2015, altogether 28 units 
reported more than 20 resections for colonic malignancies 
to the NCCR [3]. The study period included the sparse start 
of the registry and most units had not been reporting for 
two full years. The completeness of data on unit level was, 
therefore, necessarily variable and impossible to assess. No 
attempt was hence made to analyse the results on hospital 
level. Non-scheduled surgery performed within office hours 
was not possible to identify, and might be a confounder add-
ing additional burden to the open access group. Considering 
the low complication rates, the variable coverage rate on an 
institutional level may raise the suspicion of selection bias. 
Although unlikely, this cannot be completely refuted until 
more complete cohorts are gathered.
Conclusions
Our data indicate low complication rates and a high frac-
tion of uneventful patient journeys after scheduled surgery 
for colon cancer in Norway when compared to reports from 
other national registers in countries of similar population. 
Age was not associated with higher morbidity or mortality 
rates. Within the limitations of an observational study and 
in absence of stratification for tumour stage, our data show 
the use of open access technique to be associated with higher 
complication rates.
Table 7  Propensity score-adjusted odds and hazard ratios for access modality as predictor of outcomes
Numbers in parenthesis are 95% confidence intervals. Variables included when computing propensity score: age, gender, WHO ECOG score, 
mGPS, ASA score, severe pulmonary and cardiac disease, weight group and resection type. Variables included in propensity score-corrected 
logistic regression analysis: propensity score, access modality, age and gender
Any major complication Mortality Length-of-stay
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